infirst Healthcare in the press
All our press releases are in PDF format and will open in a new window.
Flarin Holdings completes oversubscribed second round of fundraising 06 April 2021 Flarin Holdings Limited (FHL), trading under the name Infirst Limited, today announces the completion of its second fund-raising round.
Following its initial investment in 2019, IW Capital again led the funding to support the exciting development of this fast-growing business.
Over the past year Flarin has seen expansion through sales of Flarin Joint and Muscular Pain Relief into mass multiples such as Boots, Superdrug, Sainsbury, Morrisons as well as Amazon, Ocado and other online retailers.
FLARIN (lipid-formulated ibuprofen) introduces
FLARIN JOINT & MUSCULAR PAIN RELIEF 15 July 2020 Infirst Ltd announces that the Flarin brand range will be expanding with the launch of Flarin Joint & Muscular Pain Relief from July 2020. Flarin Joint & Muscular Pain Relief, which has a GSL licence, will be available for consumers to self-select from the pain relief aisle.
Flarin to be trialled in COVID-19 patients 03 June 2020 Infirst Limited, a privately-owned UK healthcare company focused on improving existing medicines, today confirms that its flagship product Flarin is to be tested as a treatment for certain symptoms of hospitalised COVID-19 patients.
Flarin Holdings completes first round of fundraising to drive rapid commercialisation of world’s first lipid formulated ibuprofen 04 November 2019 Flarin Holdings Limited today announces the completion of its first round of fund-raising by IW Capital. Flarin Holdings was recently demerged from Infirst Healthcare Limited in order to provide greater focus on the rapid commercialisation of Flarin.
Infirst Healthcare Group demerges to accelerate growth of its businesses 30 October 2019 Infirst Healthcare Limited, a privately-owned UK healthcare company focused on improving existing medicines, today announces that it has demerged into three separate companies in order to accelerate growth of these separate businesses:
"Innovation of the Year - 2019 Winner CHI Awards" 28 February 2019 Infirst Healthcare’s Flarin is the winner of the CHi Award for Innovation of the Year, with one judge describing the medicine for flaring joint pain and inflammation as a “potential game changer".
The average Briton waits a YEAR before visiting their GP about apparently minor health issues